Table 5.
CAM Users | Non-CAM Users | ||
---|---|---|---|
EORTC QLQ-C30 | Mean ± SD | Mean ± SD | P-value |
Global health status QoL | 73.16 ± 20.26 | 64.82 ± 32.79 | 0.049** |
Functional Scale | |||
Physical | 68.05 ± 21.72 | 63.33 ± 28.02 | 0.055** |
Role | 78.14 ± 29.28 | 62.96 ± 42.23 | 0.002** |
Emotional | 70.78 ± 29.54 | 67.14 ± 32.39 | 0.733 |
Cognitive | 79.22 ± 24.05 | 83.33 ± 25.56 | 0.934 |
Social | 83.33 ± 26.35 | 72.22 ± 33.82 | 0.047** |
Symptom Scale | |||
Fatigue | 33.62 ± 29.13 | 41.97 ± 30.39 | 0.729 |
Nausea & Vomiting | 19.70 ± 30.55 | 12.04 ± 26.07 | 0.200 |
Pain | 33.99 ± 31.46 | 50.92 ± 28.85 | 0.424 |
Dyspnea | 25.11 ± 30.19 | 24.07 ± 29.83 | 0.614 |
Insomnia | 48.06 ± 41.01 | 40.74 ± 46.52 | 0.249 |
Appetite Loss | 31.60 ± 34.59 | 29.63 ± 41.05 | 0.151 |
Constipation | 29.01 ± 39.13 | 14.81 ± 28.52 | 0.005** |
Diarrhea | 12.99 ± 28.69 | 18.52 ± 38.30 | 0.133 |
Financial difficulties | 13.42 ± 29.25 | 20.37 ± 34.56 | 0.264 |
Note: Based on 95 Women, 18 years and above with breast cancer.
EORTC QLQ-C30: The generic European Organization for Research and Treatment of Cancer questionnaire, SD: Standard Deviation, CAM: Complementary Alternative Medicine.